Abstract
In vivo affinity maturation of antibodies involves mutation of hot spots in the DNA encoding the variable regions. We have used this information to develop a strategy to improve antibody affinity in vitro using phage display technology. In our experiment with the antimesothelin scFv, SS(scFv), we identified DNA sequences in the variable regions that are naturally prone to hypermutations, selected a few hot spots encoding nonconserved amino acids, and introduced random mutations to make libraries with a size requirement between 103 and 104 independent clones. Panning of the hot spot libraries yielded several mutants with a 15- to 55-fold increase in affinity compared with a single clone with a fourfold increased affinity from a library in which mutagenesis was done outside the hot spots. The strategy should be generally applicable for the rapid isolation of higher-affinity mutants of Fvs, Fabs, and other recombinant antibodies from antibody phage libraries that are small in size.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Waldmann, T.A. et al. Radioimmunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood 86 , 4063–4075 (1995).
Pai, L.H., Wittes, R., Setser, A., Willingham, M.C., and Pastan, I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med. 2, 350–353 (1996).
Maloney, D.G. et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 80, 2188–2195 (1997).
Osterborg, A. et al. Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. J. Clin. Oncol. 15, 1567–1574 (1997).
Baselga, J., Norton, L., Albanell, J., Kim, Y.M. & Mendelsohn, J. Recombinant humanized anti-HER2 antibody (Herceptin (M)) enhances the antitumor activity of paclitaxel and doxorubincin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 58, 2825–2831 ( 1998).
Goldhirsch, A., Coates, A.S., Castiglione-Gertsch, M. & Gelber, R.D. New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction? Ann. Oncol. 9, 973 –976 (1998).
Jain, R. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res. 50, 814s– 819s (1990).
Clauss, M.A. & Jain, R.K. Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues. Cancer Res . 50, 3487–3492 ( 1990).
Yokota, T., Milenic, D.E., Whitlow, M. & Schlom, J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402– 3408 (1992).
Adams, G.P. et al. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-C-erbB2 single chain Fv. Cancer Res . 53, 4026–4034 ( 1993).
Reiter, Y., Brinkmann, U., Lee, B. & Pastan, I. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Nat. Biotechnol. 14, 1239– 1245 (1996).
Adams, G.P. et al. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. Cancer Res. 58, 485–490 (1998).
Gram, H. et al. In vitro selection and affinity maturation of antibodies from a naïve combinatorial immunoglobulin library. Proc. Natl. Acad. Sci. USA 89, 3576–3580 ( 1992).
Low, N.M., Holliger, P. & Winter, G. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain . J. Mol. Biol. 260, 359– 368 (1996).
de Kruif, J., Boel, E. & Logtenberg, T. Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J. Mol. Biol. 248, 97–105 (1995).
Griffith, A.D. et al. Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12, 725– 734 (1993).
Barbas, C.F. et al. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230, 812– 823 (1993).
Schier, R. et al. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J. Mol. Biol. 255, 28–43 (1996).
Yelton, D.E. et al. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis. J. Immunol. 155, 1994– 2004 (1995).
Yang, W.-P. et al. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J. Mol. Biol. 254, 392–403 (1995).
Pini, A. et al. Design and use of a phage display library. J. Biol. Chem. 273, 21769–21776 (1998).
Wu, H. et al. Stepwise in vitro affinity maturation of Vitaxin, an αvβ 3-specific humanized mAb. Proc. Natl. Acad. Sci. USA 95, 6037–6042 (1998).
Neuberger, M. S. & Milstein, C. Somatic hypermutation. Curr. Biol. 7, 248–254 (1995).
Jolly, C.J. et al. The targeting of somatic hypermutation. Semin. Immunol . 8, 159–168 ( 1996).
Gonzalez-Fernandez, A., Gupta, S.K., Pannell, R., Neuberger, M.S. & Milstein, C. Somatic mutation of immunoglobulin λ chains: a segment of the major intron hypermutates as much as the complementarity-determining regions. Proc. Natl. Acad. Sci. USA 91, 12614–12618 (1994).
Golding, G.B., Gearhart, P.J. & Glickman, B.W. Patterns of somatic mutations in immunoglobulin variable genes . Genetics 115, 169– 176 (1987).
Kolchanov, N.A., Solovyov, V.V. & Rogozin, I.B. Peculiarities of immunoglobulin gene structures as a basis for somatic mutation emergence. FEBS Lett. 214, 87–91 (1987).
Rogozin, I.B., Sredneva, N.E. & Kolchanov, N.A. Somatic hypermutagenesis in immunoglobulin genes. III. Somatic mutations in the chicken light chain locus. Biochim. Biophys. Acta 1089, 175–182 (1991).
Insel, R.A. & Varade, W.S. Bias in somatic hypermutation of human V-H genes. Int. Immunol. 6, 1437– 1443 (1994).
Wagner, S.D., Milstein, C. & Neuberger, M.S. Codon bias targets mutation. Nature 376, 732 (1995).
Goyenechea, B. & Milstein, C. Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation. Proc. Natl. Acad. Sci. USA 93, 13979– 13984 (1996).
Chowdhury, P.S., Viner, J., Beers, R. & Pastan, I. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc. Natl. Acad. Sci. USA 95, 669–674 (1998).
Chang, K. & Pastan, I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc. Natl. Acad. Sci. USA 93, 136–140 (1996).
Johnson, G., Kabat, E.A. & Wu,T.T. in Weir's handbook of experimental immunology I. Immunochemistry and molecular immunology, 5th edn Ch. 6 (eds Herzenberg, L.A. Weir, W.M., Herzenberg, L.A. & Blackwell, C.) 6.1–6.21 (Blackwell Science, Cambridge, Massachusetts; 1996 ).
Chowdhury, P.S., Vasmatzis, G., Beers, R., Lee, B. & Pastan, I. Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv. J. Mol. Biol. 281 , 917–928 (1998).
Kunkel, T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82, 488– 492 (1985).
Brinkmann, U. Pai, L.H., FitzGearld, D.J. & Pastan, I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA 88, 8616–8620 (1991).
Chaudhary, V.K. et al. A recombinant immunotoxin consisting of 2 antibody variable domains fused to Pseudomonas exotoxin. Nature 339, 394–397 (1989).
Acknowledgements
The authors are thankful to Byungkook Lee, George Vasmatzis, and James Vincent for valuable criticisms and Jennie Evans for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chowdhury, P., Pastan, I. Improving antibody affinity by mimicking somatic hypermutation in vitro . Nat Biotechnol 17, 568–572 (1999). https://doi.org/10.1038/9872
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/9872
This article is cited by
-
A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis
BMC Biotechnology (2023)
-
Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates
Current Oncology Reports (2023)
-
Mesothelin as a biomarker for targeted therapy
Biomarker Research (2019)
-
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer
Scientific Reports (2017)
-
Site-saturation mutagenesis library construction and screening for specific broad-spectrum single-domain antibodies against multiple Cry1 toxins
Applied Microbiology and Biotechnology (2017)